Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc S Ernstoff

Showing results (81-90 of 169) with videos related to

Pageof 17
Sort By:
Cancer Immunology Research|September 4, 2014
BRAF inhibition alleviates immune suppression in murine autochthonous melanomaShannon M Steinberg, Peisheng Zhang, Brian T Malik, et al.
The Prostate|January 21, 2006
Tumor-related immunity in prostate cancer patients treated with human recombinant granulocyte monocyte-colony stimulating factor (GM-CSF)Thomas Schwaab, Christopher P G Tretter, Jennifer J Gibson, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 1, 2007
Phase I/II trial of outpatient PEG-interferon with interleukin-2 in advanced renal cell carcinoma: a cytokine working group studyJoseph I Clark, Jessica Mehrabi, Jeffrey A Sosman, et al.
Human Mutation|July 10, 2020
Human genes differ by their UV sensitivity estimated through analysis of UV-induced silent mutations in melanomaIvan P Gorlov, Christopher I Amos, Spiridon Tsavachidis, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 7, 2015
Histological pattern of Merkel cell carcinoma sentinel lymph node metastasis improves stratification of Stage III patientsJennifer S Ko, Victor G Prieto, Paul J Elson, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 19, 2011
Immune response in patients with newly diagnosed glioblastoma multiforme treated with intranodal autologous tumor lysate-dendritic cell vaccination after radiation chemotherapyCamilo E Fadul, Jan L Fisher, Thomas H Hampton, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 21, 2005
Phase 2 study of the g209-2M melanoma peptide vaccine and low-dose interleukin-2 in advanced melanoma: Cancer and Leukemia Group B 509901John D Roberts, Donna Niedzwiecki, William E Carson, et al.
Journal of Clinical Pharmacology|December 31, 2013
The effects of a high-fat meal on single-dose vemurafenib pharmacokineticsAntoni Ribas, Weijiang Zhang, Ilsung Chang, et al.
Journal for Immunotherapy of Cancer|April 11, 2024
Autologous human preclinical modeling of melanoma interpatient clinical responses to immunotherapeuticsYee Peng Phoon, Jared E Lopes, Lukas W Pfannenstiel, et al.
Nature Communications|March 4, 2021
T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitorsTakayoshi Yamauchi, Toshifumi Hoki, Takaaki Oba, et al.
Pageof 17

Showing results (81-90 of 169) with videos related to

Sort By:
Pageof 17
Cancer Immunology Research|September 4, 2014
BRAF inhibition alleviates immune suppression in murine autochthonous melanomaShannon M Steinberg, Peisheng Zhang, Brian T Malik, et al.
The Prostate|January 21, 2006
Tumor-related immunity in prostate cancer patients treated with human recombinant granulocyte monocyte-colony stimulating factor (GM-CSF)Thomas Schwaab, Christopher P G Tretter, Jennifer J Gibson, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 1, 2007
Phase I/II trial of outpatient PEG-interferon with interleukin-2 in advanced renal cell carcinoma: a cytokine working group studyJoseph I Clark, Jessica Mehrabi, Jeffrey A Sosman, et al.
Human Mutation|July 10, 2020
Human genes differ by their UV sensitivity estimated through analysis of UV-induced silent mutations in melanomaIvan P Gorlov, Christopher I Amos, Spiridon Tsavachidis, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 7, 2015
Histological pattern of Merkel cell carcinoma sentinel lymph node metastasis improves stratification of Stage III patientsJennifer S Ko, Victor G Prieto, Paul J Elson, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 19, 2011
Immune response in patients with newly diagnosed glioblastoma multiforme treated with intranodal autologous tumor lysate-dendritic cell vaccination after radiation chemotherapyCamilo E Fadul, Jan L Fisher, Thomas H Hampton, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 21, 2005
Phase 2 study of the g209-2M melanoma peptide vaccine and low-dose interleukin-2 in advanced melanoma: Cancer and Leukemia Group B 509901John D Roberts, Donna Niedzwiecki, William E Carson, et al.
Journal of Clinical Pharmacology|December 31, 2013
The effects of a high-fat meal on single-dose vemurafenib pharmacokineticsAntoni Ribas, Weijiang Zhang, Ilsung Chang, et al.
Journal for Immunotherapy of Cancer|April 11, 2024
Autologous human preclinical modeling of melanoma interpatient clinical responses to immunotherapeuticsYee Peng Phoon, Jared E Lopes, Lukas W Pfannenstiel, et al.
Nature Communications|March 4, 2021
T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitorsTakayoshi Yamauchi, Toshifumi Hoki, Takaaki Oba, et al.
Pageof 17